Techfields Pharma
Clinical-stage pharmaceutical company developing prodrugs and a transdermal delivery platform to enable rapid tissue penetration of approved small molecules and biologics. The approach aims to increase local bioavailability, reduce systemic dose and toxicity, and enable targeted delivery across biological barriers (skin, blood-brain, cartilage). The company has an active pipeline spanning preclinical to Phase 3 and has received regulatory designations for its lead program.
Industries
Nr. of Employees
small (1-50)
Techfields Pharma
Products
X0002
Lead prodrug program being developed for pain associated with osteoarthritis (knee and back); clinical program includes Phase 3 and has received Fast Track designation and special protocol assessment.
TF0023
Program targeting hyperinflammatory states related to COVID-19 complications; listed among clinical programs in the company's pipeline.
Early-stage pipeline programs (examples: TF0066, TF0062, TF0068)
Preclinical / early-development prodrug programs targeting neuropathic pain, depression, anti-obesity, and Parkinson’s disease.
X0002
Lead prodrug program being developed for pain associated with osteoarthritis (knee and back); clinical program includes Phase 3 and has received Fast Track designation and special protocol assessment.
TF0023
Program targeting hyperinflammatory states related to COVID-19 complications; listed among clinical programs in the company's pipeline.
Early-stage pipeline programs (examples: TF0066, TF0062, TF0068)
Preclinical / early-development prodrug programs targeting neuropathic pain, depression, anti-obesity, and Parkinson’s disease.
Services
Sponsored research and licensing collaborations
Scientific partnerships including sponsored research and licensing to apply transdermal prodrug technology to therapeutic candidates.
Sponsored research and licensing collaborations
Scientific partnerships including sponsored research and licensing to apply transdermal prodrug technology to therapeutic candidates.
Expertise Areas
- Transdermal drug delivery
- Prodrug design and development
- Topical spray/mist formulation
- Preclinical pharmacokinetics and biodistribution
Key Technologies
- Transdermal delivery platforms
- Prodrug chemistry and synthesis
- Topical spray-mist formulations
- Targeted tissue penetration techniques